HCV inhibitors

Details for Australian Patent Application No. 2007238253 (hide)

Owner Novartis AG

Inventors Seepersaud, Mohindra; Radetich, Branko; Rigollier, Pascal; Raman, Prakash; Fu, Jiping; Simic, Oliver; Cottens, Sylvain; Randl, Stefan Andreas; Parker, David Thomas; Wan, Dongpeng; Ehrhardt, Claus; Patane, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2007238253

PCT Pub. Number WO2007/121125

Priority 60/791,578 11.04.06 US

Filing date 9 April 2007

Wipo publication date 25 October 2007

International Classifications

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/10 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

25 September 2008 PCT application entered the National Phase

  PCT publication WO2007/121125 Priority application(s): WO2007/121125

23 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238257-System and methods for applying signals to neural populations

2007238252-HCV inhibitors comprising beta amino acids and their uses